// STATE LEGISLATION TRACKER

Illinois SB 1602: SEXUAL ASSAULT TREATMENT

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Signed

State: Illinois
Bill: SB 1602
Session: 104th
Filed: 2025-02-04
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Illinois SB1602 updates sexual assault emergency treatment rules and is now Public Act 104-0386. Based on the title, subjects, and status, it does not appear to regulate compounded peptides, off-label prescribing, telehealth peptide care, compounding pharmacies, controlled substances, or prescription monitoring.

Key Points

No apparent change to compounded peptide access
No apparent effect on off-label peptide prescribing
No apparent change to telehealth peptide care
No apparent change to NP or naturopathic peptide scope
No apparent impact on FDA 503A or 503B compounding

What to Watch For

Note Clinics should treat this as a sexual assault care law, not a peptide-access law.

Note Any NP references appear tied to sexual assault treatment, not broader peptide prescribing authority.

Where the Bill Stands

The bill became Illinois Public Act 104-0386 on August 15, 2025.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws